Chen v. Howard-Anderson

87 A.3d 648, 2014 Del. Ch. LEXIS 50, 2014 WL 1366551
CourtCourt of Chancery of Delaware
DecidedApril 8, 2014
DocketC.A. No. 5878-VCL
StatusPublished
Cited by92 cases

This text of 87 A.3d 648 (Chen v. Howard-Anderson) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Chen v. Howard-Anderson, 87 A.3d 648, 2014 Del. Ch. LEXIS 50, 2014 WL 1366551 (Del. Ct. App. 2014).

Opinion

[653]*653OPINION

LASTER, Vice Chancellor.

In September 2010, Occam Networks, Inc. (“Occam” or the “Company”) announced an agreement and plan of merger with Calix, Inc. (the “Merger Agreement”). The Merger Agreement called for Calix to acquire Occam through a merger in which each share of Occam common stock would be converted into the right to receive 0.2925 shares of Calix common stock and $3.83 in cash (the “Merger”). The Merger closed in February 2011. The plaintiffs contend that the defendants breached their fiduciary duties by (i) making decisions during Occam’s sale process that fell outside the range of reasonableness and (ii) issuing a proxy statement for Occam’s stockholder vote on the Merger (the “Proxy Statement”) that contained materially misleading disclosures and material omissions.

After discovery, the defendants moved for summary judgment. The defendants ask the court to rule as a matter of law that they did not breach their fiduciary duties. Alternatively, the defendants who were Occam directors contend that the evidence at most could support a breach of the duty of care, for which a provision in Occam’s certificate of incorporation exculpates them from liability (the “Exculpatory Provision”).

As to the sale process claims, the director defendants’ motion for summary judgment is granted. When the evidence is analyzed for purposes of Rule 56, with enhanced scrutiny as the standard of review, the record supports an inference that certain decisions fell outside the range of reasonableness. Nevertheless, the plaintiffs failed to develop sufficient evidence to support an inference that the directors acted with an improper motive. The Exculpatory Provision therefore insulates the director defendants from liability. The remaining defendants were officers who cannot invoke the Exculpatory Provision.

As to the disclosure claims, the motion for summary judgment is denied. When the evidence is analyzed for purposes of Rule 56, the record supports an inference that the Proxy Statement contained materially misleading disclosures and material omissions. The director defendants again invoke the Exculpatory Provision, but the record supports an inference that the defendants knew about the disclosure problems before approving the Proxy Statement. In addition, the defendants engaged in questionable conduct during discovery sufficient to support an inference that they sought to conceal evidence about potential disclosure issues until after the Merger closed. At this stage of the case, the defendants’ conduct reinforces the inference of scienter. Summary judgment on the disclosure claims is therefore denied. A trial is both necessary and desirable to inquire into and develop the facts more thoroughly before seeking to apply the law.

I. FACTUAL BACKGROUND

The record for the defendants’ summary judgment motion fills many binders, and the parties have submitted what are effectively post-trial briefs replete with extensive evidentiary citations. Each side weaves a tale out of the evidence and draws its own inferences from the documents and testimony. On a motion for summary judgment, the court cannot weigh the evidence, decide among competing inferences, or make factual findings. For purposes of this decision, Rule 56 requires that the evidence be construed in favor of the non-movant plaintiffs. What follows is therefore predominately the plaintiffs’ side of the story.

[654]*654A. Occam

Before the Merger, Occam was a publicly traded Delaware corporation based in Santa Barbara, California. Its stock traded on NASDAQ under the symbol OCNW. Occam developed, marketed, and supported products for the broadband access market.

Defendants Robert Howard-Anderson, Steven Krausz, Robert Abbott, Robert By-lin, Thomas Pardun, Brian Strom, and Albert Moyer constituted Occam’s board of directors (the “Board”). Howard-Anderson also served as Occam’s President and CEO. The other six directors were facially independent and disinterested outsiders. Two directors — Krausz and Abbott — were affiliated with investment funds that together held approximately 25% of Occam’s common stock. Krausz, who had served as an Occam director since 1997 and as Chairman of the Board since 2002, was a general partner at U.S. Venture Partners (“USVP”). Together with its affiliates, USVP beneficially owned 15% of Occam’s common stock. Abbott, who had served as an Occam director since 2002, was a general partner at Norwest Venture Partners (“Norwest”). Together with its affiliates, Norwest beneficially owned nearly 10% of Occam’s common stock.

Another key player at Occam was defendant Jeanne Seeley, who had served as Occam’s CFO since May 2008. Seeley was intimately involved in the process leading to the Merger. She was the person “running the deal” for Occam. Seeley Tr. at 181.

B. The Broadband Access Equipment Market

Analysts in the early 21st century divided the North American market for broadband access equipment into three tiers based on the size of the telecom companies who were the target customers. Occam primarily sold equipment to the Tier 3 segment, where the customers consisted of small rural service providers, many of whom relied on government subsidies. Occam had approximately 20-30% of the Tier 3 market at the time of the Merger. Occam had barely penetrated the Tier 2 segment, which consisted of larger service providers, and had no presence in the Tier 1 segment, which consisted of the largest service providers.

Calix is a Delaware corporation based in Petaluma, California. Calix did not go public until March 2010, after which its stock traded on the New York Stock Exchange under the symbol CALX. Like Occam, Calix manufactured broadband access equipment. Calix had approximately 30-40% of the Tier 3 segment. Unlike Occam, Calix had a significant presence in the Tier 2 segment.

Adtran, Inc. is a Delaware corporation based in Huntsville, Alabama. Like Occam and Calix, Adtran manufactured broadband access equipment. Adtran primarily operated in the Tier 1 and Tier 2 segments.

C. Occam Expands Into The Tier 2 Segment.

In January 2008, Occam won its first Tier 2 customer, FairPoint Communications, Inc. Occam took the business from Adtran, FairPoint’s incumbent supplier. The win demonstrated Occam’s ability to successfully compete against larger access equipment suppliers, like Calix and Ad-tran.

Occam also was circling TDS Telecom (“TDS”), another important Tier 2 customer. TDS historically used Calix as its exclusive supplier, but TDS had become dissatisfied with Calix and decided to become a two-supplier company. Going for[655]*655ward, TDS would split its purchases between Calix and a second vendor. Occam had a good shot at becoming the second vendor.

D. Krausz Explores A Potential Transaction With Calix.

In early 2009, Krausz had several calls with Carl Russo, Calix’s CEO, about a potential transaction between Occam and Calix. On March 13, Krausz reported to the Board on his activities. According to the minutes,

Mr. Krausz led a discussion concerning his recent meeting with [Calix] relating to a potential strategic transaction. A discussion ensued concerning the potential opportunities such a transaction would present to the Company and its stockholders as well as a discussion of potential risks and challenges.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Black v. Brice
W.D. North Carolina, 2025
In re Dura Medic Consolidation Litigation
Court of Chancery of Delaware, 2025
In re Match Group, Inc. Derivative Litigation
Court of Chancery of Delaware, 2024
Stephen M. Sciannella v. Astrazeneca UK Limited
Court of Chancery of Delaware, 2024
McRitchie v. Zuckerberg
Court of Chancery of Delaware, 2024
Kuramo Capital Management, LLC v. Larry Seruma
Court of Chancery of Delaware, 2024
Richard J. Tornetta v. Elon Musk
Court of Chancery of Delaware, 2024
OptimisCorp v. William Atkins
Court of Chancery of Delaware, 2023
Simon Ogus v. SportTechie, Inc.
Court of Chancery of Delaware, 2023
In Re Mindbody, Inc. Stockholder Litigation
Court of Chancery of Delaware, 2023
CARUSO v. MODANY
S.D. Indiana, 2022
Metro Storage International LLC v. Harron
Court of Chancery of Delaware, 2022
In Re: Newport Corp. Shareholder Litig.
Nevada Supreme Court, 2022

Cite This Page — Counsel Stack

Bluebook (online)
87 A.3d 648, 2014 Del. Ch. LEXIS 50, 2014 WL 1366551, Counsel Stack Legal Research, https://law.counselstack.com/opinion/chen-v-howard-anderson-delch-2014.